Avid Bioservices's Total Assets for the quarter that ended in Oct. 2024 was $323.5 Mil.
Warning Sign:
If a company builds assets at 56.9% a year, faster than its revenue growth rate of 20.8% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Avid Bioservices's average Total Assets Growth Rate was -31.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 46.20% per year.
During the past 5 years, the average Total Assets Growth Rate was 56.90% per year.
During the past 10 years, the average Total Assets Growth Rate was 34.60% per year.
During the past 13 years, Avid Bioservices's highest 3-Year average Total Assets Growth Rate was 125.40%. The lowest was -46.50%. And the median was 21.40%.
The historical data trend for Avid Bioservices's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Avid Bioservices's Total Assets for the fiscal year that ended in Apr. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avid Bioservices (NAS:CDMO) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Oct. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Avid Bioservices's Asset Turnover for the quarter that ended in Oct. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Avid Bioservices Total Assets Related Terms
Thank you for viewing the detailed overview of Avid Bioservices's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CDMO has been successfully added to your 